NCT05516914 2026-04-01
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
Clinical Trials
11 trialsNCT07112222 2026-01-26
A Study of LM-350 in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
Phase 1/2 Recruiting
NCT05790447 2023-03-30
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04787003 2023-03-23
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
North China Petroleum Bureau General Hospital
Phase 1 Unknown
NCT05755659 2023-03-06
COSEFDIP
Xijing Hospital
Phase NA Unknown
NCT03348826 2020-09-16
Study of Sodium Bicarbonate in Restoring Blocked Catheters
University Health Network, Toronto
Phase 2 Withdrawn
NCT02508441 2018-10-18
Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Andes Biotechnologies
Phase 1 Terminated
NCT01165905 2017-06-23
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Traws Pharma, Inc.
Phase 1 Completed
NCT01837667 2017-01-24
Phase I Study of LB-100 With Docetaxel in Solid Tumors
Lixte Biotechnology Holdings, Inc.
Phase 1 Completed
NCT00088023 2014-03-31
Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
Spectrum Pharmaceuticals, Inc
Phase 1 Terminated
NCT00100139 2011-07-04
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
INSYS Therapeutics Inc
Phase 1 Completed